Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Aridis Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q2 2022
- Shares held
- 1.93M
- +117.8K (+6.5%) vs. Q2 2022
- Total value
- $1.79M
- −$196.0K (−9.9%) vs. Q2 2022
- New holders
- 1
- 6 more added
- Sold out
- 2
- 4 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $2.96M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Financial Perspectives, Inc | 250 | $233 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,331 | $1.00K | 0.00% | +18+1.4% | Added |
| UBS Group AG | 3,197 | $3.00K | 0.00% | −5,096−61.4% | Reduced |
| Tower Research Capital LLC (TRC) | 10,669 | $10.0K | 0.00% | +2,592+32.1% | Added |
| Simplex Trading, LLC | 11,872 | $11.0K | 0.00% | −1,750−12.8% | Reduced |
| Wealth Architects, LLC | 14,077 | $13.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 17,448 | $16.0K | 0.00% | −287−1.6% | Reduced |
| Group One Trading, L.P. | 18,499 | $17.0K | 0.00% | −3,037−14.1% | Reduced |
| Northern Trust Corp | 28,104 | $26.0K | 0.00% | +11,532+69.6% | Added |
| State Street Corp | 43,247 | $40.0K | 0.00% | +15,200+54.2% | Added |
| EP Wealth Advisors, LLC | 50,000 | $47.0K | 0.00% | +50,000 | New |
| Citadel Advisors LLC | 54,386 | $51.0K | 0.00% | +34,905+179.2% | Added |
| Geode Capital Management, LLC | 136,021 | $126.0K | 0.00% | +25,821+23.4% | Added |
| Roumell Asset Management, LLC | 446,588 | $415.0K | 0.90% | 00.0% | Unchanged |
| Vanguard Group Inc | 524,122 | $488.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 567,200 | $527.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,804−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,342−100.0% | Sold out |
| Minot Wealth Management LLC | – | – | – | – | Not filed |
| B. Riley Wealth Management, Inc. | – | – | – | – | Not filed |